Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
No additional railway station needed in ShushaMoldovan portal covers Ilham Aliyev's WUF13 speechNeftchi's Conference League opponentsHousing crisis threatens social stabilityRussia launches nuclear drillsEvolution stock surges 10% on $2.1 billion buyback planRai Way Q1 2026 Earnings: Revenue Up, Stock RisesEU to Cut Import Duties, Avert Trump Tariff HikeBOJ Rate Hike and Bond Market MovesYouth Struggle to Buy or Rent HomesNo additional railway station needed in ShushaMoldovan portal covers Ilham Aliyev's WUF13 speechNeftchi's Conference League opponentsHousing crisis threatens social stabilityRussia launches nuclear drillsEvolution stock surges 10% on $2.1 billion buyback planRai Way Q1 2026 Earnings: Revenue Up, Stock RisesEU to Cut Import Duties, Avert Trump Tariff HikeBOJ Rate Hike and Bond Market MovesYouth Struggle to Buy or Rent Homes
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU
COMPANY

Thames Water Seeks £413m Creditor Consent

Thames Water launches tenth consent request to draw £413.49m from super senior facility. Voting set for June 2, 2026.

David Wilson
ByDavid Wilson- Senior Editor
|
0
Thames Water Seeks £413m Creditor Consent
Photo: Prepared by Bond.az

Thames Water Utilities Limited launched a tenth consent request on Monday, seeking approval from super senior creditors to waive conditions and draw £413.49 million from secured commitments.

The company has drawn £1.836 billion of the £2.25 billion available under its super senior facility. New commitments total £823 million.

The voting date is June 2, 2026. If approved, Thames Water expects further consent requests.

More News
Ocado Admits 62,729 Shares to London Stock Exchange
Today / 07:43
|
570

Ocado Admits 62,729 Shares to London Stock Exchange

Ocado Group plc admits 62,729 ordinary shares to trading on the London Stock Exchange under the Restricted Share Plan.

COMPANY →
0
Avacta reports 2025 results, raises £32.5m for oncology trials
Today / 07:04
|
876

Avacta reports 2025 results, raises £32.5m for oncology trials

Avacta Group reports 2025 preliminary results, raises £32.5 million for oncology trials. Updates on AVA6103 and AVA6000 programs.

COMPANY →
0
Greatland Issues Shares for Employee Incentive Plan
Today / 07:02
|
489

Greatland Issues Shares for Employee Incentive Plan

Greatland Resources issues 1.76 million shares for employee incentive plan at A$14.11 each. Shares to be admitted to AIM trading.

COMPANY →
0
Kidney Transplant Rejection Test Study Published
Today / 06:46
|
625

Kidney Transplant Rejection Test Study Published

Verici Dx's study on kidney transplant rejection test published in Kidney360. PTRA test predicts early acute rejection better than traditional tools.

COMPANY →
0
Power Metallic forms Saudi joint venture with Amaar Mining
Today / 06:45
|
716

Power Metallic forms Saudi joint venture with Amaar Mining

Power Metallic and Amaar Mining form 50/50 joint venture in Saudi Arabia. Initial funding of $10 million.

COMPANY →
0
Bayer's asundexian gets FDA priority review
Today / 06:43
|
917

Bayer's asundexian gets FDA priority review

FDA grants Priority Review to Bayer's asundexian for secondary stroke prevention. Phase III trial results show promise.

COMPANY →
0
Orosur Mining Issues 2.85M Shares After RSU Exercise
Today / 06:33
|
784

Orosur Mining Issues 2.85M Shares After RSU Exercise

Orosur Mining issues 2.85M shares after directors and consultants exercise RSUs. Shares to trade on AIM from May 22, 2026.

COMPANY →
0
Golden Prospect Moves Portfolio Management to Manulife
Today / 06:31
|
965

Golden Prospect Moves Portfolio Management to Manulife

Golden Prospect Precious Metals delegates portfolio management to Manulife. New managers Diana Racanelli and Craig Bethune appointed.

COMPANY →
0
SSP Group Appoints Candace McGraw to Board
Today / 06:22
|
948

SSP Group Appoints Candace McGraw to Board

SSP Group appoints Candace McGraw as independent non-executive director. Effective June 1, she brings aviation expertise.

COMPANY →
0
CBL-514: New Obesity Data Revealed
Today / 06:01
|
902

CBL-514: New Obesity Data Revealed

Caliway Biopharmaceuticals reveals new data on CBL-514 for obesity. Combination therapy boosts weight loss by 91.5%.

COMPANY →
0
Genentech to Present Breast Cancer Data at ASCO Meeting
Today / 05:21
|
881

Genentech to Present Breast Cancer Data at ASCO Meeting

Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.

COMPANY →
0
Onto Innovation prices $1.3B convertible notes
Today / 03:43
|
453

Onto Innovation prices $1.3B convertible notes

Onto Innovation prices $1.3 billion convertible senior notes due 2031 at a 50% conversion premium. Interest-free notes with strong liquidity.

COMPANY →
0
...